The Inflammatory Biomarkers Behavior Profile of Patients Following Elective Degenerative Spine Surgery and Differences Compared to Those Coursing With a Postoperative Spinal Infection: Protocol for a Systematic Review

Overview

Journal JMIR Res Protoc

Publisher JMIR Publications

Specialty General Medicine

Date 2023 Jan 27

PMID 36703491

Authors

Jose Alberto Israel Romero Rangel

Fiacro Jimenez Ponce

Rosa Maria Wong Chew

Juan Osvaldo Talavera Pina

Adolfo Martinez Tovar

Affiliations

Soon will be listed here.

Abstract

Background: The incidence of postoperative spinal infection (PSI) ranges from 0% to 10%, with devastating effects on the patient prognosis because of higher morbidity while increasing costs to the health care system. PSIs are elusive and difficult to diagnose, especially in the early postoperative state, because of confusing clinical symptoms, rise in serum biomarkers, or imaging studies. Current research on diagnosis has focused on serum biomarkers; nevertheless, most series rely on retrospective cohorts where biomarkers are studied individually and at different time points.

Objective: This paper presents the protocol for a systematic review that aims to determine the inflammatory biomarker behavior profile of patients following elective degenerative spine surgery and their differences compared to those coursing with PSIs.

Methods: The proposed systematic review will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. This protocol was registered at PROSPERO on January 19, 2022. We will include studies related to biomarkers in adult patients operated on for degenerative spinal diseases and those developing PSIs. The following information will be extracted from the papers: (1) study title; (2) study author; (3) year; (4) evidence level; (5) research type; (6) diagnosis group (elective postoperative degenerative disease or PSI); (7a) region (cervical, thoracic, lumbosacral, and coccygeal); (7b) type of infection by anatomical or radiological site; (8) surgery type (including instrumentation or not); (9) number of cases; (10) mean age or individual age; (11) individual serum biomarker values from the preoperative state up to 90 days postoperative for both groups, including (10a) interleukin-6, (10b) presepsin, (10c) erythrocyte sedimentation rate, (10d) leukocyte count, (10e) neutrophil count, (10f) C-reactive protein, (10g) serum amyloid, (10h) white cell count, (10i) albumin, (10j) prealbumin, (10k) procalcitonin, (10l) retinol-associated protein, and (10m) Dickkopf-1; (11) postoperative days at symptoms or diagnosis; (12) type of organism; (13) day of starting antibiotics; (14) duration of treatment; and (15) any biases (including comorbidities, especially those affecting immunological status). All data on biomarkers will be presented graphically over time.

Results: No ethical approval will be required, as this review is based on published data and does not involve interaction with human participants. The search for this systematic review commenced in February 2021, and we expect to publish the findings in mid-2023.

Conclusions: This study will provide the behavior profile of biomarkers for PSI and patients following elective surgery for degenerative spinal diseases from the preoperative period up to 90 days postoperative, providing cutoff values on the day of diagnosis. This research will provide clinicians with highly trustable cutoff reference values for PSI diagnosis. Finally, we expect to provide a basis for future research on biomarkers that help diagnose more accurately and in a timely manner in the early stages of illness, ultimately impacting the patient's physical and mental health, and reducing the disease burden.

Trial Registration: PROSPERO CRD42022304645; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=304645.

International Registered Report Identifier (irrid): DERR1-10.2196/41555.

References

Madhavan K, Onn Chieng L, Armstrong V, Wang M . Spondylodiscitis in end-stage renal disease: a systematic review. J Neurosurg Spine. 2019; 30(5):674-682. DOI: 10.3171/2018.9.SPINE18824. View

Salvetti D, Tempel Z, Goldschmidt E, Colwell N, Angriman F, Panczykowski D . Low preoperative serum prealbumin levels and the postoperative surgical site infection risk in elective spine surgery: a consecutive series. J Neurosurg Spine. 2018; 29(5):549-552. DOI: 10.3171/2018.3.SPINE171183. View

Liu J, Deng H, Chen X, Zhou Y, Yang D, Duan M . Risk Factors for Surgical Site Infection After Posterior Lumbar Spinal Surgery. Spine (Phila Pa 1976). 2017; 43(10):732-737. DOI: 10.1097/BRS.0000000000002419. View

Nasto L, Colangelo D, Rossi B, Fantoni M, Pola E . Post-operative spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012; 16 Suppl 2:50-7. View

Badia J, Casey A, Petrosillo N, Hudson P, Mitchell S, Crosby C . Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017; 96(1):1-15. DOI: 10.1016/j.jhin.2017.03.004. View

Fujita R, Takahata M, Kokabu T, Oda I, Kajino T, Hisada Y . Retrospective study to evaluate the clinical significance of a second rise in C-reactive protein level following instrumented spinal fusion surgery. J Orthop Sci. 2019; 24(6):963-968. DOI: 10.1016/j.jos.2019.09.002. View

Bowler P . Wound pathophysiology, infection and therapeutic options. Ann Med. 2003; 34(6):419-27. DOI: 10.1080/078538902321012360. View

Silva-Garcia O, Valdez-Alarcon J, Baizabal-Aguirre V . Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria. Front Immunol. 2019; 10:2135. PMC: 6776594. DOI: 10.3389/fimmu.2019.02135. View

Zarate-Kalfopulos B, Juarez-Jimenez H, Alpizar-Aguirre A, Rosales-Olivares L, Sanchez-Bringas G, Reyes-Sanchez A . Postoperative spinal wound infections treated by external spinal fixator. Review of three cases. Cir Cir. 2011; 78(5):430-4. View

10.

Aljabi Y, Manca A, Ryan J, Elshawarby A . Value of procalcitonin as a marker of surgical site infection following spinal surgery. Surgeon. 2018; 17(2):97-101. DOI: 10.1016/j.surge.2018.05.006. View

11.

Inose H, Kobayashi Y, Yuasa M, Hirai T, Yoshii T, Okawa A . Procalcitonin and Neutrophil Lymphocyte Ratio After Spinal Instrumentation Surgery. Spine (Phila Pa 1976). 2019; 44(23):E1356-E1361. DOI: 10.1097/BRS.0000000000003157. View

12.

Kraft C, Kruger T, Westhoff J, Luring C, Weber O, Wirtz D . CRP and leukocyte-count after lumbar spine surgery: fusion vs. nucleotomy. Acta Orthop. 2011; 82(4):489-93. PMC: 3237042. DOI: 10.3109/17453674.2011.588854. View

13.

Epstein N . Preoperative measures to prevent/minimize risk of surgical site infection in spinal surgery. Surg Neurol Int. 2019; 9:251. PMC: 6302553. DOI: 10.4103/sni.sni_372_18. View

14.

Blumberg T, Woelber E, Bellabarba C, Bransford R, Spina N . Predictors of increased cost and length of stay in the treatment of postoperative spine surgical site infection. Spine J. 2017; 18(2):300-306. DOI: 10.1016/j.spinee.2017.07.173. View

15.

Khan M, Smith P, Rao N, Donaldson W . Serum C-reactive protein levels correlate with clinical response in patients treated with antibiotics for wound infections after spinal surgery. Spine J. 2006; 6(3):311-5. DOI: 10.1016/j.spinee.2005.07.006. View

16.

Inose H, Kobayashi Y, Yuasa M, Hirai T, Yoshii T, Okawa A . Postoperative lymphocyte percentage and neutrophil-lymphocyte ratio are useful markers for the early prediction of surgical site infection in spinal decompression surgery. J Orthop Surg (Hong Kong). 2020; 28(2):2309499020918402. DOI: 10.1177/2309499020918402. View

17.

Yamamoto Y, Iwata E, Shigematsu H, Nakajima H, Tanaka M, Okuda A . Comparison of neutrophil and lymphocyte at 1 and 4 days postoperatively: reliable and early detection markers for surgical site infection following instrumented spinal fusion. Spine Surg Relat Res. 2019; 2(2):127-134. PMC: 6698500. DOI: 10.22603/ssrr.2017-0052. View

18.

Kudo D, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Mizutani T . Relationship between preoperative serum rapid turnover proteins and early-stage surgical wound infection after spine surgery. Eur Spine J. 2016; 26(12):3156-3161. DOI: 10.1007/s00586-016-4855-z. View

19.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009; 151(4):W65-94. DOI: 10.7326/0003-4819-151-4-200908180-00136. View

20.

Deng H, Chan A, Ammanuel S, Chan A, Oh T, Skrehot H . Risk factors for deep surgical site infection following thoracolumbar spinal surgery. J Neurosurg Spine. 2020; 32(2):292-301. View